BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1107261 HOUSTON, TX

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$608,685

-$189,707 QoQ

Shares Held

130,900

-11.8% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#38

of 124 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. AVIR ranks #30 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$608,685	130,900	-11.8%	Shares	Sole	2026-08-14
2026-03-31	$798,392	148,400	0.0%	Shares	Sole	2026-05-15
2025-12-31	$529,788	148,400	+3.7%	Shares	Sole	2026-02-17
2025-09-30	$414,990	143,100	0.0%	Shares	Sole	2025-11-14
2025-06-30	$515,160	143,100	0.0%	Shares	Sole	2025-08-14
2025-03-31	$427,869	143,100	+329.7%	Shares	Sole	2025-05-15
2024-12-31	$111,555	33,300	-91.2%	Shares	Sole	2025-02-14
2023-09-30	$1,139,736	379,912	0.0%	Shares	Sole	2023-11-14
2023-06-30	$1,420,870	379,912	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,272,705	379,912	-2.1%	Shares	Sole	2023-05-15
2022-12-31	$1,865,856	387,912	+9.1%	Shares	Sole	2023-02-14
2022-09-30	$2,023,432	355,612	+2.3%	Shares	Sole	2022-11-14
2022-06-30	$2,468,045	347,612	+1201.9%	Shares	Sole	2022-08-15
2022-03-31	$192,774	26,700	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.